Steve Elms's Net Worth

$1.43 Million

Who is Steve Elms?

Steve Elms has an estimated net worth of $1.43 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., Zeltiq Aesthetics Inc, CEMPRA, INC., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., SafeStitch Medical, Inc., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., Marker Therapeutics, Inc., AMBIT BIOSCIENCES CORP, PERNIX THERAPEUTICS HOLDINGS, INC., INTERPHARM HOLDINGS INC, and Adams Respiratory Therapeutics, Inc..

SEC CIK

Steve Elms's CIK is 0001250195

Past Insider Trading and Trends

2014 was Steve Elms's most active year for acquiring shares with 5 total transactions. Steve Elms's most active month to acquire stocks was the month of May. 2019 was Steve Elms's most active year for disposing of shares, totalling 5 transactions. Steve Elms's most active month to dispose stocks was the month of January. 2022 saw Steve Elms paying a total of $0.00 for 159,758 shares, this is the most they've acquired in one year. In 2019 Steve Elms cashed out on 50,999 shares for a total of $11,984,765.00, their largest year based on trade value.